Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation : Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

M Lehto; A Luojus; O Halminen; J Haukka; O Lehtonen; P Tiili; AL Aro; J Putaala; M Linna; P Mustonen; J Kinnunen; M Niemi; J Hartikainen; KEJ Airaksinen; FinACAF Study Group

doi:10.1093/eurheartj/ehad655.542

Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation : Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

M Lehto, A Luojus, O Halminen, J Haukka, O Lehtonen, P Tiili, AL Aro, J Putaala, M Linna, P Mustonen, J Kinnunen, M Niemi, J Hartikainen, KEJ Airaksinen, FinACAF Study Group

Department of Industrial Engineering and Management

Research output: Contribution to journal › Meeting Abstract › Scientific › peer-review

Original language	English
Article number	ehad655.542
Number of pages	2
Journal	European Heart Journal
Volume	44
Issue number	Suppl. 2
DOIs	https://doi.org/10.1093/eurheartj/ehad655.542
Publication status	Published - 9 Nov 2023
MoE publication type	Not Eligible
Event	European Society of Cardiology Congress - Amsterdam, Netherlands Duration: 25 Aug 2023 → 28 Aug 2023

Access to Document

10.1093/eurheartj/ehad655.542

Cite this

Lehto, M., Luojus, A., Halminen, O., Haukka, J., Lehtonen, O., Tiili, P., Aro, AL., Putaala, J., Linna, M., Mustonen, P., Kinnunen, J., Niemi, M., Hartikainen, J., Airaksinen, KEJ., & FinACAF Study Group (2023). Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation : Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study. European Heart Journal, 44(Suppl. 2), Article ehad655.542. https://doi.org/10.1093/eurheartj/ehad655.542

@article{393aa919d825419f94d9c6bda73a799f,

title = "Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation : Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study",

author = "M Lehto and A Luojus and O Halminen and J Haukka and O Lehtonen and P Tiili and AL Aro and J Putaala and M Linna and P Mustonen and J Kinnunen and M Niemi and J Hartikainen and KEJ Airaksinen and {FinACAF Study Group}",

year = "2023",

month = nov,

day = "9",

doi = "10.1093/eurheartj/ehad655.542",

language = "English",

volume = "44",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Suppl. 2",

note = "European Society of Cardiology Congress, ESC ; Conference date: 25-08-2023 Through 28-08-2023",

}

Lehto, M, Luojus, A, Halminen, O, Haukka, J, Lehtonen, O, Tiili, P, Aro, AL, Putaala, J, Linna, M, Mustonen, P, Kinnunen, J, Niemi, M, Hartikainen, J, Airaksinen, KEJ & FinACAF Study Group 2023, 'Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation : Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study', European Heart Journal, vol. 44, no. Suppl. 2, ehad655.542. https://doi.org/10.1093/eurheartj/ehad655.542

Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation : Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study. / Lehto, M; Luojus, A; Halminen, O et al.
In: European Heart Journal, Vol. 44, No. Suppl. 2, ehad655.542, 09.11.2023.

Research output: Contribution to journal › Meeting Abstract › Scientific › peer-review

TY - JOUR

T1 - Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation : Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

AU - Lehto, M

AU - Luojus, A

AU - Halminen, O

AU - Haukka, J

AU - Lehtonen, O

AU - Tiili, P

AU - Aro, AL

AU - Putaala, J

AU - Linna, M

AU - Mustonen, P

AU - Kinnunen, J

AU - Niemi, M

AU - Hartikainen, J

AU - Airaksinen, KEJ

AU - FinACAF Study Group

PY - 2023/11/9

Y1 - 2023/11/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=aalto_pure&SrcAuth=WosAPI&KeyUT=WOS:001115619400543&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1093/eurheartj/ehad655.542

DO - 10.1093/eurheartj/ehad655.542

M3 - Meeting Abstract

SN - 0195-668X

VL - 44

JO - European Heart Journal

JF - European Heart Journal

IS - Suppl. 2

M1 - ehad655.542

T2 - European Society of Cardiology Congress

Y2 - 25 August 2023 through 28 August 2023

ER -

Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation : Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

Access to Document

Other files and links

Cite this